{"id":2903,"date":"2026-09-06T16:13:54","date_gmt":"2026-09-06T16:13:54","guid":{"rendered":"https:\/\/bookinghospital.org\/?p=2903"},"modified":"2026-09-06T16:41:31","modified_gmt":"2026-09-06T16:41:31","slug":"hepatitis-b-or-c-and-kidney-transplant","status":"publish","type":"post","link":"https:\/\/bookinghospital.org\/tr\/hepatit-b-veya-c-ve-bobrek-nakli\/","title":{"rendered":"Hepatit B veya C ve B\u00f6brek Nakli"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"2903\" class=\"elementor elementor-2903\">\n\t\t\t\t<div class=\"elementor-element elementor-element-10a363b e-con-full e-flex e-con e-parent\" data-id=\"10a363b\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c9af283 elementor-widget elementor-widget-html\" data-id=\"c9af283\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!-- ============================================================\n     BOOKINGHOSPITAL \u2014 MAKALE 05-B\n     Kaynak: \"Kidney Transplantation - With Questions and Answers\",\n             Prof. Dr. Murat Tuncer \u2014 Bolum: Patients with hepatitis B and\/or C\n     slug   : hepatitis-kidney-transplant\n     baslik : Hepatitis B or C and Kidney Transplant\n\n     ONCE: BH-ORTAK-CSS.txt Customizer -> Additional CSS icinde olmali.\n\n     SURERANK:\n     SEO Title : Hepatitis B & C Kidney Transplant: Are You Still Eligible?\n     Meta Desc : Told you cannot have a kidney transplant because of hepatitis B or C?\n                 A transplant professor explains why hepatitis is no longer an obstacle,\n                 and what actually rules a patient out.\n\n     NOT: Kaynak metindeki \"interferon tedavisi\" ifadesi cikarildi \u2014 guncel\n          uygulamada dogrudan etkili antiviraller (DAA) kullaniliyor. Yerine\n          ilac adi vermeden \"aktif karaciger hastaligi once tedavi edilir\"\n          ilkesi birakildi. Kullaniciya soruldu.\n     ============================================================ -->\n<div id=\"bh\">\n\n<section class=\"hero\">\n  <div class=\"in\">\n    <p class=\"eyebrow\">B\u00f6brek nakli \u00b7 Nakil \u00f6ncesi<\/p>\n    <h1>Hepatit B veya C kap\u0131y\u0131 kapatmaz<\/h1>\n    <p class=\"lead\">Bir\u00e7ok hastaya, hepatitlerinin nakle engel oldu\u011fu s\u00f6ylenmektedir. \u00c7o\u011fu i\u00e7in bu durum y\u0131llard\u0131r ge\u00e7erli de\u011fildir ve reddetme karar\u0131n\u0131n arkas\u0131ndaki gerek\u00e7e genellikle g\u00fcncelli\u011fini yitirmi\u015ftir.<\/p>\n    <p class=\"meta\">Yazan <b style=\"color:#fff\">Prof. Dr. Murat Tuncer<\/b> \u00b7\n       Kitab\u0131ndan uyarlanm\u0131\u015ft\u0131r <i>B\u00f6brek Nakli \u2014 Soru ve Cevaplarla<\/i><\/p>\n  <\/div>\n<\/section>\n\n<section class=\"wrap\">\n\n  <div class=\"ozet\">\n    <h2>K\u0131sa cevap<\/h2>\n    <ul>\n      <li>Hepatit B, hepatit C veya her ikisine sahip hastalar <b>nakledilebilir<\/b> \u2014 karaci\u011fer halihaz\u0131rda sirotik de\u011filse.<\/li>\n      <li>\u0130leri d\u00fczey karaci\u011fer hasar\u0131, yakla\u015f\u0131k olarak <b>1%<\/b> nakil adaylar\u0131n\u0131n. Bu, bir istisnad\u0131r, kural de\u011fil.<\/li>\n      <li>Hepatit B i\u00e7in modern antiviral ila\u00e7lar ve rutin profilaksi uzun s\u00fcreli sa\u011fkal\u0131m sa\u011flam\u0131\u015ft\u0131r <b>hepatit negatif al\u0131c\u0131lar\u0131nkine yak\u0131n<\/b>.<\/li>\n      <li>Hepatit C i\u00e7in nakil ge\u00e7iren hastalar <b>\u00e7ok daha d\u00fc\u015f\u00fck \u00f6l\u00fcm oran\u0131<\/b>\n          diyalizde kalan hepatit C hastalar\u0131ndan.<\/li>\n      <li>E\u011fer siroz mevcutse, soru \"b\u00f6brek\"ten\n          <b>\"kombine karaci\u011fer ve b\u00f6brek\"<\/b> \u2014 ki bu hala bir nakildir, bir reddetme de\u011fildir.<\/li>\n    <\/ul>\n  <\/div>\n\n  <h2>Hepatitin neden eskiden bir engel oldu\u011fu \u2014 ve neden art\u0131k olmad\u0131\u011f\u0131<\/h2>\n\n  <p>Hepatit, diyaliz hastalar\u0131 aras\u0131nda h\u00e2l\u00e2 \u00f6nemli bir sorun olmaya devam etmektedir. Prevalans\u0131n d\u00fc\u015f\u00fck oldu\u011fu \u00fclkelerde,\n     diyaliz hastalar\u0131 aras\u0131nda hepatit B y\u00fczey antijeni (HBsAg) pozitifli\u011fi\n     %0 ile %7% aras\u0131nda de\u011fi\u015fmektedir. Endemik b\u00f6lgelerde ise bu oran <b>10 ila 20%<\/b>. Hepatit C de benzer \u015fekilde a\u015f\u0131r\u0131 temsil edilmektedir; bunun ba\u015fl\u0131ca nedenleri kan nakilleri ve diyaliz \u00fcnitelerindeki bula\u015fmalard\u0131r.<\/p>\n\n  <p>Y\u0131llar boyunca bu, ihtiyat anlam\u0131na geliyor ve bir\u00e7ok merkezde reddedilmeyi beraberinde getiriyordu. \u0130ki geli\u015fme bunu de\u011fi\u015ftirdi: etkili antiviral ila\u00e7lar\u0131n ortaya \u00e7\u0131k\u0131\u015f\u0131 ve nakilden hemen sonra koruyucu tedavi uygulama uygulamas\u0131.<\/p>\n\n  <div class=\"box\">\n    <span class=\"etiket\">Ne de\u011fi\u015fti<\/span>\n    <p>Hepatit B pozitif al\u0131c\u0131lar\u0131n g\u00fcn\u00fcm\u00fczdeki uzun s\u00fcreli sa\u011fkal\u0131m oranlar\u0131 <b>hepatit B negatif al\u0131c\u0131lar\u0131nkine yakla\u015fmak<\/b>. Bir zamanlar y\u00fcksek riskli bir prosed\u00fcr olarak ele al\u0131nan \u015fey, rutin bir uygulama haline gelmi\u015ftir.<\/p>\n  <\/div>\n\n  <h2>Hepatit B<\/h2>\n\n  <p><b>Hepatit B enfeksiyonu b\u00f6brek nakli i\u00e7in bir engel de\u011fildir.<\/b> Bu ba\u015flang\u0131\u00e7 pozisyonudur ve istisnalar genel olmaktan ziyade spesifiktir.<\/p>\n\n  <h3>Nakilden \u00f6nce ne yap\u0131lmal\u0131<\/h3>\n\n  <ul>\n    <li><b>Her aday test edilir<\/b> hepatit B i\u00e7in bilinen bir \u00f6yk\u00fc olsun ya da olmas\u0131n.<\/li>\n    <li>E\u011fer bir hasta HBsAg pozitifse <b>ve<\/b> viral replikasyon belirte\u00e7leri g\u00f6steren (HBeAg pozitifli\u011fi ve\/veya HBV-DNA pozitifli\u011fi), bir <b>biyopsi dahil kapsaml\u0131 karaci\u011fer de\u011ferlendirmesi<\/b> \u015fartt\u0131r \u2014 \u00e7\u00fcnk\u00fc bu grupta transplantasyon sonras\u0131 ilerleyici karaci\u011fer hastal\u0131\u011f\u0131 riski artmaktad\u0131r.<\/li>\n    <li>E\u011fer aktif karaci\u011fer hastal\u0131\u011f\u0131 tespit edilirse, bu durum <b>\u00f6nceden tedavi edilmi\u015f<\/b> nakil, ret gerek\u00e7esi olarak kullan\u0131lmaz.<\/li>\n    <li>E\u011fer <b>siroz<\/b> g\u00fcn\u00fcm\u00fczde sadece b\u00f6brek nakli uygun de\u011fildir. Bunun yerine hasta \u015fu de\u011ferlendirilmelidir: <b>kombine karaci\u011fer ve b\u00f6brek nakli<\/b>.<\/li>\n  <\/ul>\n\n  <h3>Nakilden Sonra<\/h3>\n\n  <p>Ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lanmas\u0131 vir\u00fcs\u00fcn yeniden aktifle\u015fmesine neden olabilir, bu nedenle \u00f6nleyici antiviral tedavi uygulanmaktad\u0131r. Mevcut k\u0131lavuzlar \u015funu \u00f6nermektedir: <b>evrensel profilaksi<\/b> imm\u00fcnos\u00fcpresyon s\u0131ras\u0131nda reaktivasyon riski orta ila y\u00fcksek olan t\u00fcm hastalar i\u00e7in \u2014 yani tedavi, yaln\u0131zca sorun belirtileri g\u00f6sterenlere de\u011fil, risk grubundaki herkese uygulan\u0131r.<\/p>\n\n  <p>Hepatit B pozitif nakilde t\u00fcm imm\u00fcnosupresif ila\u00e7lar kullan\u0131labilir. Temel kural, <b>en d\u00fc\u015f\u00fck i\u015flevsel d\u00fczeyde toplam imm\u00fcnosupresyon<\/b> uzun vadede.<\/p>\n\n  <div class=\"box\">\n    <span class=\"etiket\">A\u015f\u0131lama \u2014 g\u00f6zden ka\u00e7an k\u0131s\u0131m<\/span>\n    <p>A\u015f\u0131lama, hepatit B'ye kar\u015f\u0131 tek ba\u015f\u0131na en etkili eylemdir ve <b>Zamanlama \u00f6nemlidir<\/b>. Kronik b\u00f6brek hastalar\u0131 a\u015f\u0131land\u0131klar\u0131nda \u00e7ok daha iyi yan\u0131t verirler.\n      <b>\u00f6nce<\/b> yakla\u015f\u0131k olarak diyalize ba\u015fl\u0131yorlar <b>90% ile 70% Kar\u015f\u0131la\u015ft\u0131rmas\u0131<\/b> \u0130mm\u00fcnojenisite.<\/p>\n    <p>Halihaz\u0131rda diyalize giriyorsan\u0131z, y\u0131ll\u0131k anti-HBs antikor titresi ile yine de a\u015f\u0131lanmal\u0131s\u0131n\u0131z. <b>10 IU\/mL'nin alt\u0131ndaysa, bir rapel doz gereklidir.<\/b> Seninkinin en son ne zaman kontrol edildi\u011fini sor.<\/p>\n  <\/div>\n\n  <div class=\"soru\">\n    <h3>Ben hepatit B ta\u015f\u0131y\u0131c\u0131s\u0131y\u0131m. K\u0131z\u0131ma b\u00f6brek ba\u011f\u0131\u015flayabilir miyim?<\/h3>\n\n    <p><b>Evet, belirli ko\u015fullar alt\u0131nda.<\/b> Hepatit B enfekte don\u00f6rlerden (canl\u0131 veya kadavra) al\u0131nan b\u00f6brekler; ister a\u015f\u0131lama yoluyla ister ge\u00e7mi\u015f enfeksiyondan kaynaklans\u0131n, ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 olan veya kendileri HBsAg pozitif olan al\u0131c\u0131lara nakledilebilir. Bilgilendirilmi\u015f onam gereklidir ve al\u0131c\u0131n\u0131n HBsAb titre de\u011ferinin 10'un \u00fczerinde olmas\u0131 gerekir.<\/p>\n\n    <p>Bu, kan\u0131t bekleyen marjinal bir uygulama de\u011fildir. <b>Bu soru \u00fczerine d\u00fcnyadaki ilk \u00e7al\u0131\u015fmalardan biri ekibimiz taraf\u0131ndan ger\u00e7ekle\u015ftirilmi\u015ftir.<\/b><sup>1<\/sup><\/p>\n  <\/div>\n\n  <h2>Hepatit C<\/h2>\n\n  <p>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc, d\u00fcnya genelinde hepatit C prevalans\u0131n\u0131 yakla\u015f\u0131k 3% olarak tahmin etmektedir \u2014\n     yakla\u015f\u0131k 71 milyon ki\u015fi. B\u00f6brek hastalar\u0131 aras\u0131nda ise bu hastal\u0131k \u00e7ok daha yayg\u0131nd\u0131r.<\/p>\n\n  <p>Hepatit C, karaci\u011fer hasar\u0131n\u0131 k\u00f6t\u00fcle\u015ftirebilece\u011fi ve transplant glomer\u00fclopatisi, transplantasyon sonras\u0131 yeni ba\u015flang\u0131\u00e7l\u0131 diyabet ile lenfoproliferatif bozukluklar\u0131n bilinen bir nedeni oldu\u011fu i\u00e7in nakilde \u00f6nem ta\u015f\u0131r. Ayr\u0131ca, temel olarak miks kriyoglobulinemiden kaynaklanan membranoproliferatif glomer\u00fclonefrit yoluyla ilk etapta kronik b\u00f6brek hastal\u0131\u011f\u0131na da neden olabilir.<\/p>\n\n  <p>Bunlar\u0131n hi\u00e7birisi bunu bir engel haline getirmez.<\/p>\n\n  <div class=\"box\">\n    <span class=\"etiket\">\u00d6nemli olan kar\u015f\u0131la\u015ft\u0131rma<\/span>\n    <p>Hepatit C pozitif hastalar\u0131n mortalite oran\u0131 <b>b\u00f6brek nakli olan ki\u015fi<\/b>\n      diyalizde kalan hepatit C pozitif hastalar\u0131nkinden \u2014 \u00f6zellikle de nakil sonras\u0131ndaki ilk on y\u0131l boyunca \u2014 belirgin \u015fekilde daha d\u00fc\u015f\u00fckt\u00fcr.<\/p>\n    <p>Ba\u015fka bir deyi\u015fle, bir hepatit C hastas\u0131na nakil yapman\u0131n riskleri, [...] riskine kar\u015f\u0131 tart\u0131lmal\u0131d\u0131r <b>de\u011fil<\/b> onlar\u0131 ba\u015fka bir yere dikmek. \u0130kinci risk genellikle daha b\u00fcy\u00fck olan\u0131d\u0131r.<\/p>\n  <\/div>\n\n  <h3>Nakilden \u00f6nce ne yap\u0131lmal\u0131<\/h3>\n\n  <ul>\n    <li><b>Her aday test edilir<\/b> anti-HCV antikorlar\u0131 i\u00e7in.<\/li>\n    <li>olan hastalar <b>anti-HCV pozitif ancak HCV RNA negatif<\/b> transplantasyon sonras\u0131 karaci\u011fer hastal\u0131\u011f\u0131 riski \u00e7ok d\u00fc\u015f\u00fckt\u00fcr.<\/li>\n    <li>A <b>karaci\u011fer biyopsisi<\/b> HCV pozitifli\u011fine y\u00fcksek transaminazlar\u0131n e\u015flik etti\u011fi durumlarda yap\u0131lmal\u0131d\u0131r. Transaminaz seviyeleri diyaliz hastalar\u0131nda g\u00fcvenilir bir g\u00f6sterge olmad\u0131\u011f\u0131ndan, baz\u0131 klinisyenler hepatit C pozitif t\u00fcm adaylar i\u00e7in biyopsi \u00f6nermektedir.<\/li>\n    <li>Hepatit B'de oldu\u011fu gibi, <b>siroz<\/b> soruyu kombine karaci\u011fer ve b\u00f6brek nakline y\u00f6nlendirir.<\/li>\n    <li>Aktif kronik hepatit <b>\u00f6nceden tedavi edilmi\u015f<\/b> transplantasyon.<\/li>\n  <\/ul>\n\n  <div class=\"soru\">\n    <h3>Hepatit C pozitifim. Negatif olan o\u011fluma ba\u011f\u0131\u015f yapabilir miyim?<\/h3>\n\n    <p>Bu, uzun s\u00fcre imk\u00e2ns\u0131z g\u00f6r\u00fcl\u00fcyordu. Art\u0131k aktif bir uygulama alan\u0131.<\/p>\n\n    <p>The <b>EXPANDER-1 \u00e7al\u0131\u015fmas\u0131<\/b> Johns Hopkins \u00dcniversitesi'ndeki ara\u015ft\u0131rmac\u0131lar tam olarak bunu inceledi: Hepatit C ile enfekte don\u00f6rlerden al\u0131nan b\u00f6brekler, hepatit C negatif al\u0131c\u0131lara nakledildi; nakirden hemen sonra antiviral tedaviye ba\u015fland\u0131 ve don\u00f6r\u00fcn viral genotipine g\u00f6re ayarlanarak on iki hafta boyunca s\u00fcrd\u00fcr\u00fcld\u00fc.<\/p>\n\n    <p>2017 y\u0131l\u0131nda Amerikan Transplantasyon Kongresi'nde sunulan sonu\u00e7lar sekiz hastay\u0131 kaps\u0131yordu. <b>Tedavi sonras\u0131nda hi\u00e7birinde Hepatit C RNA tespit edilmedi ve greft yetmezli\u011fi g\u00f6zlenmedi.<\/b><sup>2,3<\/sup><\/p>\n\n    <p>Hepatit C pozitif don\u00f6rlerden al\u0131nan b\u00f6brekler de onay al\u0131narak hepatit C RNA pozitif al\u0131c\u0131lara nakledilebilir. Bu durumda, hem don\u00f6r\u00fcn hem de al\u0131c\u0131n\u0131n genotiplerinin belirlenmesi uygundur.<\/p>\n  <\/div>\n\n  <h2>Peki, bir hastada te\u015fhisi kesin olarak ne d\u0131\u015flar?<\/h2>\n\n  <p>Bu konuda do\u011frudan olmakta fayda var, \u00e7\u00fcnk\u00fc belirsiz reddetmeler net olanlardan daha fazla zarar verir. Hepatit ba\u011flam\u0131nda, ger\u00e7ek engeller dar kapsaml\u0131d\u0131r:<\/p>\n\n  <div class=\"tblwrap\">\n    <table>\n      <thead>\n        <tr><th>Bulgu<\/th><th>Ne anlama geliyor<\/th><\/tr>\n      <\/thead>\n      <tbody>\n        <tr>\n          <td>Hepatit B veya C, karaci\u011fer sirozlu de\u011fil<\/td>\n          <td><b>Transplantasyon devam edebilir<\/b>, uygun de\u011ferlendirme ve profilaksi ile<\/td>\n        <\/tr>\n        <tr>\n          <td>Kopyalama belirte\u00e7leri mevcut<\/td>\n          <td>Biyopsi dahil tam karaci\u011fer de\u011ferlendirmesi \u00f6nce \u2014 ard\u0131ndan karar verin<\/td>\n        <\/tr>\n        <tr>\n          <td>Aktif karaci\u011fer hastal\u0131\u011f\u0131<\/td>\n          <td>\u00d6nce tedavi edildi, ard\u0131ndan yeniden de\u011ferlendirildi<\/td>\n        <\/tr>\n        <tr>\n          <td><b>Siroz<\/b><\/td>\n          <td>Yaln\u0131zca b\u00f6brek uygun de\u011fildir \u2014 de\u011ferlendirilmesi gereken durum: <b>kombine karaci\u011fer ve b\u00f6brek<\/b><\/td>\n        <\/tr>\n        <tr>\n          <td><b>Aktif hepatit<\/b> ameliyat s\u0131ras\u0131nda<\/td>\n          <td>Kontrol alt\u0131na al\u0131nana kadar kesin bir kontrendikasyon<\/td>\n        <\/tr>\n      <\/tbody>\n    <\/table>\n  <\/div>\n\n  <p>Son s\u00fctunun ne kadar dar oldu\u011funa dikkat edin. \u0130leri d\u00fczey karaci\u011fer bulgular\u0131 yakla\u015f\u0131k olarak <b>1%<\/b> potansiyel al\u0131c\u0131dan. E\u011fer reddedildyseniz, bu sat\u0131rlardan hangisinin sizin i\u00e7in ge\u00e7erli oldu\u011funu \u2014ve hala ge\u00e7erli olup olmad\u0131\u011f\u0131n\u0131\u2014 belirlemeye de\u011fer.<\/p>\n\n  <div class=\"yazar\">\n    <div class=\"rozet\">MT<\/div>\n    <div>\n      <h3>Prof. Dr. Murat Tuncer<\/h3>\n      <p>Nefrolog ve nakil hekimi. Yazar\u0131: <i>B\u00f6brek Nakli \u2014 Soru ve Cevaplarla<\/i> (\u0130stanbul, 2020). Yay\u0131mlanan \u00e7al\u0131\u015fmalar\u0131 aras\u0131nda, hepatitis B y\u00fczey antijeni pozitif canl\u0131 vericilerden b\u00f6brek ba\u011f\u0131\u015f\u0131 konusunda d\u00fcnya \u00e7ap\u0131ndaki ilk \u00e7al\u0131\u015fmalardan biri ve T\u00fcrkiye'de ger\u00e7ekle\u015ftirilen ilk ABO uyumsuz b\u00f6brek nakilleri yer almaktad\u0131r.<\/p>\n    <\/div>\n  <\/div>\n\n  <div class=\"cta\">\n    <h2>Hepatit nedeniyle reddedildi mi? Raporlar\u0131 bize g\u00f6nderin<\/h2>\n    <p>Bize hepatit serolojinizi, karaci\u011fer fonksiyon testlerinizi ve varsa biyopsi sonu\u00e7lar\u0131n\u0131z\u0131 getirin. Cevab\u0131n \u00f6yle oldu\u011fu durumlar da dahil olmak \u00fczere, g\u00fcncel uygulamalara g\u00f6re reddedilme karar\u0131n\u0131n hala ge\u00e7erli olup olmad\u0131\u011f\u0131n\u0131 size d\u00fcr\u00fcst\u00e7e s\u00f6yleyece\u011fiz.<\/p>\n    <div class=\"btns\">\n      <a class=\"btn btn-1\" href=\"\/medical-tourism\/\">T\u0131bbi raporlar\u0131n\u0131z\u0131 g\u00f6nderin<\/a>\n      <a class=\"btn btn-2\" href=\"\/kidney-transplant-compatibility\/\">Kan grubu ve doku e\u015fle\u015fmesi<\/a>\n    <\/div>\n  <\/div>\n\n  <div class=\"uyari\">\n    <p><b>T\u0131bbi sorumluluk reddi.<\/b> Bu makale, yay\u0131mlanm\u0131\u015f bir kitaptan uyarlanan genel bilgiler i\u00e7ermektedir. Ki\u015fisel t\u0131bbi tavsiye niteli\u011finde de\u011fildir, doktor-hasta ili\u015fkisi kurmaz ve sizi tedavi eden hekimin de\u011ferlendirmesinin yerini alamaz. Antiviral rejimler ve nakil protokolleri merkezler aras\u0131nda farkl\u0131l\u0131k g\u00f6sterir ve zamanla de\u011fi\u015febilir. Tedaviniz hakk\u0131nda karar vermeden \u00f6nce her zaman kendi nefrolo\u011funuza, hepatolo\u011funuza veya nakil merkezinize dan\u0131\u015f\u0131n.<\/p>\n  <\/div>\n\n  <div class=\"kaynak\">\n    <h3>Kaynak\u00e7a<\/h3>\n    <ol>\n      <li class=\"kendi\"><b>Tuncer M<\/b>, Tekin S, Yucetin L, Sengul A, Demirbas A. Hepatit B y\u00fczey antijeni pozisli\u011fi canl\u0131 b\u00f6brek ba\u011f\u0131\u015f\u0131 i\u00e7in bir kontrendikasyon de\u011fildir.\n        <i>Transplant Proc<\/i> 2012;44(6):1628\u20139.<\/li>\n      <li>Durand C, Brown D, Wesson R ve ark. EXPANDER-1: HCV negatif al\u0131c\u0131lar i\u00e7in hepatit C enfekte don\u00f6rleri kullanan renal nakillerin incelenmesi.\n        <i>Am J Transplant<\/i> 2017;17(ek 3).<\/li>\n      <li>Molnar MZ, ve ark. Hepatit C enfekte don\u00f6rlerden hepatit C negatif al\u0131c\u0131lara b\u00f6brek nakli: tek merkez deneyimi.\n        <i>Am J Transplant<\/i> 2019;19(11):3046\u201357.<\/li>\n      <li>Marinaki S, Kolovou K, Sakellariou S, Boletis JN, Delladetsima IK. B\u00f6brek nakli hastalar\u0131nda Hepatit B. <i>World J Hepatol<\/i> 2017;9(25):1054\u201363.<\/li>\n      <li>Lai TS, Lee MH, Yang HI, et al. Hepatit C viral y\u00fck\u00fc, genotipi ve son d\u00f6nem b\u00f6brek hastal\u0131\u011f\u0131 geli\u015fme riskindeki art\u0131\u015f: REVEAL-HCV \u00e7al\u0131\u015fmas\u0131.\n        <i>Hepatoloji<\/i> 2017;66:784\u201393.<\/li>\n    <\/ol>\n  <\/div>\n\n<\/section>\n\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Kidney transplantation \u00b7 Before the transplant Hepatitis B or C does not close the door Many patients are told their hepatitis rules out a transplant. For most, that has not been true for years \u2014 and the reasoning behind the refusal is often out of date. Written by Prof. Dr. Murat Tuncer \u00b7 Adapted from [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"_surecart_dashboard_logo_width":"180px","_surecart_dashboard_show_logo":true,"_surecart_dashboard_navigation_orders":true,"_surecart_dashboard_navigation_invoices":true,"_surecart_dashboard_navigation_subscriptions":true,"_surecart_dashboard_navigation_downloads":true,"_surecart_dashboard_navigation_billing":true,"_surecart_dashboard_navigation_account":true,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_joinchat":[],"footnotes":""},"categories":[16],"tags":[],"class_list":["post-2903","post","type-post","status-publish","format-standard","hentry","category-kidney-transplant-guide"],"_links":{"self":[{"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/posts\/2903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/comments?post=2903"}],"version-history":[{"count":4,"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/posts\/2903\/revisions"}],"predecessor-version":[{"id":2909,"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/posts\/2903\/revisions\/2909"}],"wp:attachment":[{"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/media?parent=2903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/categories?post=2903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bookinghospital.org\/tr\/wp-json\/wp\/v2\/tags?post=2903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}